Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis
J Allergy Clin Immunol Pract
.
2024 Feb 27:S2213-2198(24)00205-8.
doi: 10.1016/j.jaip.2024.02.031.
Online ahead of print.
Authors
Jerry Fu
1
,
Twan Sia
2
,
Rachel Solecki
1
,
Shibani Mallik
1
,
Raisa Khuda
1
,
Madison Headen
1
,
Leeon Bacchus
1
,
Michelle Zheng
1
,
Tanvi Telukunta
1
,
Saad Shami
1
,
Stanley Liu
1
,
Sripad Sureshbabu
1
,
Kathleen Love
1
,
Alyssa Roby
1
,
Paige McDonald
1
,
Yuting Jiang
1
,
Dharaneswari Hari Narayanan
1
,
Evan Cunningham
3
,
Amina Sara Matmatte
1
,
Puay Eng Tan
4
,
John Leung
5
Affiliations
1
Boston Specialists, Boston, Mass.
2
School of Medicine, Stanford University, Stanford, Calif.
3
School of Medicine, University of Connecticut, Storrs, Conn.
4
Department of Pathology & Lab Services, Carney Hospital, Dorchester, Mass.
5
Boston Specialists, Boston, Mass. Electronic address: drjohnleung@bfac.org.
PMID:
38423296
DOI:
10.1016/j.jaip.2024.02.031
No abstract available